Datavault AI, Wellgistics Form DelivMeds AI Joint Venture, Acquiring Health Data, Drone IP, and Tollo Health
DVLT sits 83% above its 52-week low of $0.251.
Summary
Datavault AI and Wellgistics Health are forming a new joint venture named DelivMeds AI. This strategic initiative involves expanding the PharmacyChain license and acquiring QOLPOM Biometric Health Data, Drone Logistics IP, and a majority stake in Tollo Health. This move represents a significant strategic expansion for Datavault AI, diversifying its offerings into health data and logistics. This follows recent Q1 2026 reports for Datavault AI that showed a substantially widened net loss and increased cash burn, suggesting this partnership could be a strategic effort to drive future growth. While the financial terms of the deal are not disclosed, the formation of a new entity and multiple acquisitions indicate a material impact on both DVLT and WGRX. Investors will be watching for further details on the financial structure, funding requirements, and expected synergies of DelivMeds AI.
At the time of this announcement, DVLT was trading at $0.46 on NASDAQ in the Technology sector, with a market capitalization of approximately $386.4M. The 52-week trading range was $0.25 to $4.10. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.